Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Affinity Asset Advisors, LLC CNTX Context Therapeutics Inc. 13G/A 2.06% 2y
Karpus Management, Inc. FTII FutureTech II Acquisition Corp. 13G/A 9.68% 2y
Bialecki Andrew KVYO Klaviyo, Inc. 13G 70.8% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC LSTR Landstar System Inc 13G/A 8.98% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC FCN Fti Consulting, Inc 13G/A 9.53% 2y
BANK OF AMERICA CORP /DE/ INVZ Innoviz Technologies Ltd. 13G/A 0.4% 2y
Archon Capital Management LLC STIM Neuronetics, Inc. 13G/A 8.77% 2y
WISeKey International Holding AG LAES SEALSQ Corp 13G 38.9% 2y
FULLER & THALER ASSET MANAGEMENT, INC. SR Spire Inc 13G 6.89% 2y
Long Pond Capital, LP FOR Forestar Group Inc. 13G/A 1.8% 2y
Stephen Altemus LUNR Intuitive Machines, Inc. 13G 41.6% 2y
GENERAL ATLANTIC, L.P. PHVS Pharvaris N.V. 13G/A 14.1% 2y
Polar Capital Holdings Plc NSTG NanoString Technologies, Inc. 13G/A 8.26% 2y
David Moradi AEYE Audioeye Inc 13G/A 29.3% 2y
EnCap Partners GP, LLC PR Permian Resources Corp 13G/A 12.58% 2y
MSD Partners, L.P. LIND Lindblad Expeditions Holdings, Inc. 13G/A 6.7% 2y
Niraj Shah W Wayfair Inc. 13G/A 11.5% 2y
Polar Asset Management Partners Inc. ABLV Able View Global Inc. 13G/A 2.5% 2y
Bos Teresa D. ONEW OneWater Marine Inc. 13G/A 5.6% 2y
BB Biotech AG AGIO Agios Pharmaceuticals, Inc. 13G/A 7.2% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC NCNO nCino, Inc. 13G 6.43% 2y
INVESTMENTAKTIENGESELLSCHAFT FUER LANGFRISTIGE INVESTOREN TGV TCX Tucows Inc 13G/A 18.5% 2y
Channing Capital Management, LLC SPHR Sphere Entertainment Co. 13G 5.02% 2y
William T. Dillard, II DDS Dillard's, Inc. 13G/A 7.5% 2y
Novartis AG OCS Oculis Holding AG 13G/A 4.7% 2y
Pacific Investment Management Company LLC EVGO EVgo Inc. 13G/A 3.5% 2y
JANUS HENDERSON GROUP PLC ICUI Icu Medical Inc 13G/A 10.8% 2y
Frederic Simon FROG JFrog Ltd 13G/A 4.5% 2y
M&G INVESTMENT MANAGEMENT LTD ARBE Arbe Robotics Ltd. 13G/A 4.8% 2y
Dodge & Cox MET Metlife Inc 13G/A 7.2% 2y
GATES FOUNDATION TRUST EMF Templeton Emerging Markets Fund 13G 5.1% 2y
PRINCIPAL REAL ESTATE INVESTORS, LLC KRC Kilroy Realty Corp 13G/A 4.16% 2y
Dasilva Dax LSPD Lightspeed Commerce Inc. 13G/A 9.38% 2y
GLAZER CAPITAL, LLC ADOC Edoc Acquisition Corp. Class A Ordinary Share 13G/A 0% 2y
Avidity Partners Management LP ZNTL Zentalis Pharmaceuticals, Inc. 13G/A 0% 2y
BCLS II Equity Opportunities, LP SYRE Spyre Therapeutics, Inc. 13G/A 0% 2y
Stonepine Capital Management, LLC GMDA Gamida Cell Ltd. Ordinary Shares 13G/A 2.2% 2y
Dr. Stephen Mulholland INMD InMode Ltd. 13G/A 3.54% 2y
Gemini Asia Holdings Limited AXG Solowin Holdings, Ltd. 13G 26.3% 2y
Grantham, Mayo, Van Otterloo & Co. LLC GYRO Gyrodyne, LLC 13G/A 7.57% 2y
Mizuho Financial Group, Inc. GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares 13G 7.67% 2y
PRINCIPAL GLOBAL INVESTORS, LLC CCRN Cross Country Healthcare Inc 13G 5.6% 2y
ATW SPAC MANAGEMENT LLC SMNR Semnur Pharmaceuticals, Inc. 13G/A 0% 2y
Polar Asset Management Partners Inc. CHEA Chenghe Acquisition Co. Class A Ordinary Share 13G/A 1.9% 2y
JB CAPITAL PARTNERS LP FLNT Fluent, Inc. 13G/A 6.1% 2y
GLAZER CAPITAL, LLC PRSR Prospector Capital Corp. Class A Ordinary Shares 13G/A 0% 2y
MMCAP International Inc. SPC PET Wag! Group Co. Common Stock 13G/A 4.55% 2y
PRINCIPAL REAL ESTATE INVESTORS, LLC SBRA Sabra Health Care REIT, Inc. 13G/A 8.6% 2y
Hallen Ed KVYO Klaviyo, Inc. 13G 44.7% 2y
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC SLM SLM Corp 13G/A 5.42% 2y